Apyx Medical (APYX) Corporation announces it has received 510(k) clearance from the U.S. Food and Drug Administration for the AYON Body Contouring System. The Company is actively preparing for a commercial launch of AYON with key surgeons in critical geographies starting in the second half of 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APYX: